Trials / Completed
CompletedNCT05248906
Giant Cell Arteritis - Optimization of Diagnostics
Giant Cell Arteritis - Examination of the Optimal Diagnostic Pathway
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Giant cell arteritis - Optimization of diagnostics
Detailed description
A prospective study. Investigating the use of ultrasound, temporal artery biopsy, biomarkers and 18F-fluorodeoxyglucose positron emission tomography-computed tomography for establishing a diagnosis of giant cell (temporal) arteritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Giant cell arteritis | Ultrasound 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography Temporal artery biopsy |
Timeline
- Start date
- 2021-03-19
- Primary completion
- 2024-01-01
- Completion
- 2024-01-01
- First posted
- 2022-02-21
- Last updated
- 2025-04-02
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05248906. Inclusion in this directory is not an endorsement.